CAS 752240-01-0

MK-0941 free base

CAS : 752240-01-0

MK-0941: an oral glucokinase activator for type 2 diabetes with potent glucose-lowering effects.

Formule : C₂₁H₂₄N₄O₆S

Degré de pureté : 98.75%

Couleur et forme : Solid

Masse moléculaire : 460.5

Ref: TM-T12056

MK-0941 free base

CAS : 752240-01-0

MK-0941 free base

Degré de pureté : ≥98%

Masse moléculaire : 460.5g/mol

Ref: 54-BUP04208

MK-0941

CAS : 752240-01-0

MK-0941 is an analog of a medicinal compound that has shown potent anticancer activity in Chinese hamster ovary cells. This compound is a kinase inhibitor that targets specific proteins involved in cancer cell growth and survival. MK-0941 has been shown to induce apoptosis, or programmed cell death, in human leukemia cells. It also inhibits the growth of tumor cells in vitro and in vivo. This inhibitor has been found to be effective against a variety of cancers, including breast, lung, and colon cancer. In addition, it has been found to be excreted primarily through urine, making it a promising candidate for cancer treatment with low toxicity. Overall, MK-0941 is an exciting new development in the field of anticancer drugs that shows great promise for future treatments.

Formule : C₂₁H₂₄N₄O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 460.5 g/mol

Ref: 3D-CFB24001